Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Ophthalmic Genetics
|
August 21, 2020
Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings
Lindsay A McGrath, Jane M Palmer, Andrew Stark, et al.
Immunogenetics
|
June 1, 2019
Correction to: Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A Johansson, Andrew Stark, Jane M Palmer, et al.
Immunogenetics
|
February 5, 2019
Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A Johansson, Andrew Stark, Jane M Palmer, et al.
FEBS Letters
|
August 7, 2002
Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth
Steven B Levery, Michelle Momany, Rebecca Lindsey, et al.
Cancers
|
August 7, 2021
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine
Sophie Gardrat, Alexandre Houy, Kelly Brooks, et al.
Nature Communications
|
January 12, 2021
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Piyushkumar A Mundra, Nathalie Dhomen, Manuel Rodrigues, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 2, 2026
Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma
Peter A Johansson, Kelly Brooks, Jane M Palmer, et al.
Nature Communications
|
May 17, 2020
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Peter A Johansson, Kelly Brooks, Felicity Newell, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Ophthalmic Genetics
|
August 21, 2020
Genomic analysis of adult case of ocular surface giant congenital melanocytic nevus and associated clinicopathological findings
Lindsay A McGrath, Jane M Palmer, Andrew Stark, et al.
Immunogenetics
|
June 1, 2019
Correction to: Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A Johansson, Andrew Stark, Jane M Palmer, et al.
Immunogenetics
|
February 5, 2019
Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab
Peter A Johansson, Andrew Stark, Jane M Palmer, et al.
FEBS Letters
|
August 7, 2002
Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth
Steven B Levery, Michelle Momany, Rebecca Lindsey, et al.
Cancers
|
August 7, 2021
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine
Sophie Gardrat, Alexandre Houy, Kelly Brooks, et al.
Nature Communications
|
January 12, 2021
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Piyushkumar A Mundra, Nathalie Dhomen, Manuel Rodrigues, et al.
British Journal of Cancer
|
May 21, 2019
A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2018
A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium
Stephanie Lheureux, Anna Tinker, Blaise Clarke, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 2, 2026
Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma
Peter A Johansson, Kelly Brooks, Jane M Palmer, et al.
Nature Communications
|
May 17, 2020
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Peter A Johansson, Kelly Brooks, Felicity Newell, et al.
Page
of 3